Alcon Pharmaceuticals Buying Israeli Glaucoma Treatment Developer Belkin Vision
Belkin Vision has developed an efficient, non-contact, and automated glaucoma laser therapy accessible to all ophthalmologists.
United Kingdom United States Israel General Michael Belkin Hebrew University Of Jerusalem America Alcon Pharmaceuticals
Source: jewishbusinessnews.com